Sie sind auf Seite 1von 3

Singapore

O&G Ltd.

Singapore O&G Ltd.


34 Cassia Crescent, #01-80, Singapore 390034
Corporate website: www.sog.com.sg

Caring for Women's Health

NICHE PLAY INTO WOMENS HEALTHCARE IN SINGAPORE AND THE REGION


A Group of Specialists Dedicated towards Womens Healthcare

Committed and Experienced Management Team

Disciplined and Focused Direction in Delivering a Wide Range of Services for Womens Health

Conveniently-located with 8 Clinics in 5 Locations in the Central & East Regions of Singapore

OUR BUSINESS
OBSTETRICS

GENERAL
OBSTETRICS, LABOUR
AND DELIVERY

OUR MAIN REVENUE


GENERATING SERVICES

GYNAECOLOGY

GENERAL
GYNAECOLOGY

MEDICAL PROBLEMS
IN PREGNANCY

GYNAECOLOGIC
SURGERY

OBSTETRICAL
COMPLICATIONS AND
ITS MANAGEMENT

FEMALE PELVIC MEDICINE


/ UROGYNAECOLOGY
AND RECONSTRUCTIVE
SURGERY

BREAST CARE
SERVICES AND
GYNAE-ONCOLOGY

ANTENATAL CARE

DELIVERY AND
SURGICAL SERVICES

LAPAROSCOPIC
AND RELATED
PROCEDURES

GYNAE-ONCOLOGICAL
SURGERY

BREAST CARE
SERVICES

GYNAE-ONCOLOGY
SERVICES

CLINICAL
PROCEDURES

BREAST AND
GENERAL SURGERY

SCREENING
AND TESTING

THE SALE OF
MEDICATION AND
SUPPLEMENTS

SURGICAL AND
ANCILLARY
SERVICES

OUR SPECIALISTS

DR. RADHIKA
LAKSHMANAN

DR. LEE
KEEN WHYE

DR. HENG
TUNG LAN

DR. CHOO
WAN LING

DR. BEH
SUAN TIONG

DR. CINDY
PANG

DR. NATALIE
CHUA

General surgeon
with a special
interest in
breast cancer
treatment and
oncoplastic
breast surgery

O&G specialist
with special
interest in
minimally
invasive surgery
and vaginal
rejuvenation

O&G specialist,
highly sought
after for her
medical and
interpersonal
skills

O&G specialist
with strong
focus in
pregnancy care

O&G specialist
with a particular
interest in
minimally
invasive surgery

O&G specialist
with a special
interest in
gynaecological
cancer care

O&G specialist,
aspiring,
energetic and
dedicated

OUR AREA OF OPERATIONS


GLENEAGLES MEDICAL
CENTRE
(3 CLINICS)

MOUNT ELIZABETH
NOVENA SPECIALIST
CENTRE

THOMSON MEDICAL
CENTRE

PARKWAY EAST
MEDICAL CENTRE
(2 CLINICS)

CASSIA CRESCENT

INVESTMENT HIGHLIGHTS
GROWTH POTENTIAL

ATTRACTIVE DIVIDEND YIELD

PRIVATE SECTOR MADE UP 60.22% OF LIVE BIRTHS


IN SINGAPORE FOR CY2013

TARGETS TO DISTRIBUTE DIVIDENDS OF UP TO


90% OF NET PROFIT AFTER TAX FOR FY2015

THE GROUPS MARKET SHARE INCREASED TO 5.6%


FOR CY2014, FROM 4.4% FOR CY2013 AND 4.3%
FOR CY2012

ASSUMING AN IPO PRICE OF S$0.25, DIVIDEND


YIELD WOULD BE 7.3%1 BASED ON FY2014
EARNINGS AND 90.0% PAYOUT

FAVOURABLE INDUSTRY TRENDS

HEALTHY DEMAND FOR


PRIVATE O&G SERVICES *
103
0.26%

2011

111
0.26%
15,872
40.03%

2012

23,679
59.71%
Public sector hospitals

GROWTH IN
CANCER NOTIFICATIONS 2
2011

155
0.39%
16,403
38.45%

2013

26,149
61.29%

15,646
39.39%

23,919
60.22%

Private sector hospitals

Other locations

GOVERNMENT INITIATIVES TO
INCREASE NATIONAL BIRTH RATE
BABY BONUS SCHEME

Introduced in 2001 and enhanced in 2013


Helps parents lighten the cost of raising children

ASSISTED CONCEPTION PROCEDURES




Helps couples who have difficulty conceiving


Greater flexibility in using Medisave for treatments
Government will co-fund cost of treatments

CHILD DEVELOPMENT ACCOUNT


Special savings account which will be matched dollar


for dollar by the Government up till a certain limit

PARENTHOOD TAX REBATE


Given to married Singapore tax residents to offset


income tax payable

MATERNITY LEAVE

Entitled to 16 weeks of paid maternity leave

PARENTHOOD PRIORITY SCHEME


Helps first-time married


purchase their first home

couples

with

children

2013 *

2012

11,680

12,185

12,664

Notifications

Notifications

Notifications

In Singapore, the top 5 leading cancers for females3 (based


on incidence rates for 2009 to 2013) are Breast, Colo-rectum,
Lung, Corpus uteri and Ovary.
In 2014, our Group incorporated 2 new clinics and engaged
Dr. Pang and Dr. Radhika, both of whom have a special interest
in cancers.

RISE OF SINGAPORE
AS A MEDICAL TOURISM HUB *

Foreigners accounted for approximately 29.9% of the live


births registered in 2013
It is estimated that 400,0004 foreigners travel to
Singapore to seek medical treatment
Fathers
Nationality

Singapore

Malaysia

Indonesia

Other
ASEAN

China

Others

No. of Live Births

27,897

2,336

656

1,209

1,401

6,221

Percentage (%)

70.23

5.88

1.65

3.04

3.53

15.66

FUTURE PLANS

EXPANSION

INVESTMENTS

DIVERSIFYING

OF BUSINESS

IN HEALTHCARE

AND GROWING

OPERATIONS

PROFESSIONALS

OUR PATIENT

LOCALLY AND

AND SYNERGISTIC

BASE

REGIONALLY

BUSINESSES

*As of the date hereof, official figures for 2014 are not yet available
1
Dividend yield is calculated based on the post-Invitation share capital of our Company of 218,000,000 shares.
2
Table 5.1 of the Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009-2013 provided by the National Registry of Diseases Office on its website: https://www.nrdo.
gov.sg/uploadedFiles/NRDO/Cancer%20Trends%20Report%202009-2013%2020141103.pdf.
3
The MOHs Singapore Health Facts entitled Disease Burden on its website: http://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.html.
4
SingaporeMedicine: http://www.singaporemedicine.com/abt_us/abt_us1.asp.

FINANCIAL HIGHLIGHTS
Revenue/ Profit from Operations

Net Profit and Net Profit Margin

15.0

5.0

13.5

5.0*

4.0
10.0

37.0%

2.0
5.0

3.4

5.8*

3.7

3.1

3.0

3.0

8.6

8.1

36.1%

37.2%*

40.0%
30.0%

1.0

20.0%
10.0%

FY12

(S$M)

Revenue

FY13

FY14

FY12

(S$M)

Profit from Operations

*Excluding one-off pre-IPO expenses of S$0.8 million

FY13

Net Profit

FY14

Net Profit Margin

*Excluding one-off pre-IPO expenses of S$0.8 million

EPS (Adjusted for New Shares)(cents)2

Dividend Policy
Proposed dividend payout of
up to 90.0% for FY2015

1.95
1.95

2.0

Dividends to be paid to shareholders


on Singapore O&G Ltds net profit after tax
for each financial year
Assuming an IPO price of S$0.25, dividend
yield would be 7.3%1 based on FY2014
earnings and 90.0% payout

Dividend yield is calculated based on the post-Invitation share capital


of our Company of 218,000,000 shares.
1

1.43

1.38

1.5
1.0
0.5

FY12

FY13

FY14

For comparative purposes, EPS is calculated based on the


Profit after tax for the year and the post-Invitation share
capital of our Company of 218,000,000 shares.
2

Statement of Financial Position


Audited
As at 31 December 2012

Audited
As at 31 December 2013

Audited
As at 31 December 2014

5,545

8,020

13,412

307

407

1,444

(910)

(1,658)

(2,987)

(75)

(7)

(13)

Shareholders Equity

4,868

6,761

11,856

NTA

4,868

6,761

11,856

200

200

174,400

2.79

3.88

6.80

(S$000)

Current Assets
Non-current Assets
Current Liabilities
Non-current Liabilities

Number of Shares
NTA per Share (cents)3
3

For comparative purposes, NTA per Share is calculated based on the net tangible assets and the pre-Invitation share capital of our Company of 174,400,000 shares.